Endurance Wealth Management, Inc. Kaleido Biosciences, Inc. Transaction History

Endurance Wealth Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$0.05 - $1.7 $50 - $1,700	-1,000 Closed	0 $0
Q4 2021 Jan 19, 2022	BUY	$2.39 - $6.02 $2,390 - $6,020	1,000 New	1,000 $2,000
Q3 2021 Oct 28, 2021	SELL	$5.36 - $7.99 $5,360 - $7,990	-1,000 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$7.2 - $16.82 $7,200 - $16,820	1,000 New	1,000 $8,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Endurance Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Endurance Wealth Management, Inc. with notifications on news.